In a clinical trial environment, Quantitative Imaging can provide valuable information about a tumor’s biology and help clinicians design adaptive therapies for their patient. However, before novel therapies can be used in humans, they must be validated in preclinical trials. Therefore, developing standards that can transcend species and imaging modalities is essential for advancing the science and utility of Quantitative Imaging.